Xylem (XYL) Competitors

Parker-Hannifin (NYSE:PH) and Xylem (NYSE:XYL) are both large-cap industrials companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations, community ranking and institutional ownership.

Do analysts recommend PH or XYL?

Parker-Hannifin currently has a consensus price target of $718.44, suggesting a potential upside of 7.17%. Xylem has a consensus price target of $146.88, suggesting a potential upside of 15.88%. Given Xylem's higher probable upside, analysts clearly believe Xylem is more favorable than Parker-Hannifin.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Parker-Hannifin	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81
Xylem	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70

Is PH or XYL more profitable?

Parker-Hannifin has a net margin of 15.87% compared to Xylem's net margin of 10.40%. Parker-Hannifin's return on equity of 27.34% beat Xylem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Parker-Hannifin	15.87%	27.34%	11.64%
Xylem	10.40%	9.96%	6.48%

Does the MarketBeat Community believe in PH or XYL?

Parker-Hannifin received 203 more outperform votes than Xylem when rated by MarketBeat users. Likewise, 63.79% of users gave Parker-Hannifin an outperform vote while only 63.39% of users gave Xylem an outperform vote.

Company	Underperform	Outperform
Parker-Hannifin	Outperform Votes 738 63.79%	Underperform Votes 419 36.21%
Xylem	Outperform Votes 535 63.39%	Underperform Votes 309 36.61%

Which has better valuation and earnings, PH or XYL?

Parker-Hannifin has higher revenue and earnings than Xylem. Parker-Hannifin is trading at a lower price-to-earnings ratio than Xylem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Parker-Hannifin	$19.79B	4.33	$2.84B	$25.97	25.81
Xylem	$8.60B	3.59	$890M	$3.72	34.07

Is PH or XYL a better dividend stock?

Parker-Hannifin pays an annual dividend of $7.20 per share and has a dividend yield of 1.1%. Xylem pays an annual dividend of $1.60 per share and has a dividend yield of 1.3%. Parker-Hannifin pays out 27.7% of its earnings in the form of a dividend. Xylem pays out 43.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Parker-Hannifin has raised its dividend for 70 consecutive years and Xylem has raised its dividend for 2 consecutive years.

Which has more volatility & risk, PH or XYL?

Parker-Hannifin has a beta of 1.36, suggesting that its stock price is 36% more volatile than the S&P 500. Comparatively, Xylem has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.

Does the media favor PH or XYL?

In the previous week, Parker-Hannifin had 16 more articles in the media than Xylem. MarketBeat recorded 35 mentions for Parker-Hannifin and 19 mentions for Xylem. Xylem's average media sentiment score of 1.46 beat Parker-Hannifin's score of 1.45 indicating that Xylem is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Parker-Hannifin	31 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Xylem	17 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders have more ownership in PH or XYL?

82.4% of Parker-Hannifin shares are owned by institutional investors. Comparatively, 88.0% of Xylem shares are owned by institutional investors. 0.4% of Parker-Hannifin shares are owned by insiders. Comparatively, 0.3% of Xylem shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Parker-Hannifin beats Xylem on 16 of the 21 factors compared between the two stocks.